Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062526 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
A Early Phase 1 study of Parkinson Disease and Healthy Volunteer, sponsored by University of Pennsylvania.
- Active
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04062526: Active Early Phase 1 study of Parkinson Disease and Healthy Volunteer, sponsored by University of Pennsylvania.
NCT04062526 is a Early Phase 1 study of Parkinson Disease and Healthy Volunteer that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 11 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04062526, a Early Phase 1 study of Parkinson Disease and Healthy Volunteer, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an imaging drug called 18F-NOS which will be used to measure inflammation in the brain.
Primary Outcome
Characterize the uptake of \[18F\]NOS in the human brain for healthy controls and PD patients.
Conditions Studied
Interventions
- DRUG [18F]NOS
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2026-04 |
| Phase | Early Phase 1 |
What the registry record for NCT04062526 still lists
NCT04062526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which [18F]NOS is the first listed.
NCT04062526 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04062526 about?
NCT04062526 is a clinical study titled "Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT". The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an ...
What is the current status of trial NCT04062526?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2019-08-14. Estimated completion is 2026-04.
What conditions does trial NCT04062526 study?
This clinical trial studies the following conditions: Parkinson Disease, Healthy Volunteer.
What interventions are being tested in trial NCT04062526?
The interventions under investigation include: [18F]NOS (DRUG).
Who is sponsoring clinical trial NCT04062526?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04062526 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04062526's enrollment target sits among peer trials
11 275th of 297 higher than 23 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
RECRUITING · Early Phase 1
-
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
RECRUITING · Early Phase 1
-
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
RECRUITING · Early Phase 1
-
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
RECRUITING · Early Phase 1
-
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
RECRUITING · Early Phase 1
-
Quantitative Imaging of Brain Glymphatic Function in Humans
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI